Grand Pharma
Manufacturing · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
160 Qiaokou Rd, Wuhan, Hubei, 430032, Ch...Phone Number
+86 4009909697Website
www.grandpharma.cnRevenue
$17.5 MillionIndustry
About Grand Pharma
Grand Pharma Org Chart
Is Grand Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Grand Pharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Grand Pharma
Grand Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Grand Pharma launches new products
Click to see if Grand Pharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Grand Pharma has new funding data
Earning: See what the market has to say on Grand Pharma recently announced quarterly report
Check out if Grand Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Grand Pharma
Find 3 more new buyers
Company Profile Activity
Activity Insights
Grand Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Grand Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Grand Pharma.
Grand Pharma Tech Stack
A closer look at the technologies used by Grand Pharma
Grand Pharma News & Media
ITM and Grand Pharma Enter into a Commercialization Agreement for Targeted Radiopharmaceuticals in the Greater China Area
MUNICH & GARCHING, Germany & HONG KONG--(BUSINESS WIRE)--ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Grand Pharmaceutical Group Limited (GP) a diversified global pharmaceutical company listed in Hong Kong, today announced that they have entered into an exclusive licensing agreement for GP to develop, manufacture and commercialize ITM’s oncological radiopharmaceutical candidates, ITM-11 (n.c.a. 177Lu-edotreotide) and ITM-41 (n.c.a. 177Lu-zoledronaCoRISMA MCS Systems Secures $27 Million in Funding to Advance Heart...
Investment will enable the company to accelerate development and expand availability of the CoRISMA cardiac treatment device (PRWeb August 30, 2021) Read the full story at https://www.prweb.com/releases/corisma_mcs_systems_secures_27_million_in_funding_to_advance_heart_failure_treatment_technology/prweb18161807.htmALK and Grandpharma team up to market the first adrenaline autoinjector in China
ALK and the pharmaceutical company China Grand Pharmaceutical and Healthcare Holdings Limited (”Grandpharma”) today announced an exclusive licensing agreement that will see ALK’s AAI Jext® registered and launched in China, and will expand ALK's presence in the country.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Grand Pharma
Grand Pharmaceutical Group Limited is an innovative international pharmaceutical company based in Wuhan, with a history dating back to 1939. The company specializes in nuclear medicine, oncology treatment, and cardiovascular precision intervention, integrating pharmaceutical technology and biotechnology. It operates multiple global R&D centers and... Read More